We confirmed that Pygo2 expression was attenuated in breast cancer tissues with high miR‐516a‐3p level compared with breast cancer tissues exhibiting low miR‐516a‐3p level through IHC staining analysis. This evidence concerns the gene PYGO2 and breast cancer.